InvestorsHub Logo
Followers 1
Posts 139
Boards Moderated 0
Alias Born 01/13/2014

Re: ubmmg post# 66117

Wednesday, 04/25/2018 1:48:55 PM

Wednesday, April 25, 2018 1:48:55 PM

Post# of 108192
I see this one:

Poster Board: #246 • Abstract 5019
KEYNOTE-046: ADXS-PSA plus pembrolizumab (pembro) in metastatic castration-resistant prostate cancer (mCRPC).

Mark N. Stein, MD - First Author
Columbia University Medical Center
Discussed at the Poster Discussion Session on Saturday, June 2, 2018, 4:45 PM - 6:00 PM, at S406
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News